Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orchid Chemicals and Pharmaceuticals Ltd
Orchid Chemicals and Pharmaceuticals Ltd
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Hospira completes purchase of Orchid\'s API manufacturing and R&D facility
US$218m acquisition paves way for future development
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Pharmaceutical
New anti-infectives company formed
Allecra Therapeutics to develop novel antibiotics to combat multi drug-resistant bacterial infections
You need to be a subscriber to read this article.
Click here
to find out more.
Finance
Mega deals and job cuts
Mergers and acquisitions, job cuts as companies streamlined their operations and cut costs, and investments in new plants were the main features of the pharmaceutical industry in 2012
Ingredients
Hospira to buy API manufacturing and r&d facilities in India
Purchase from Orchid will support continuity of antibiotic API supply
Finance
Hospira completes acquisition of Orchid's generic injectables business
Gains new manufacturing capabilities and expands global reach
Subscribe now